Attached files

file filename
EX-23.1 - CONSENT OF WITHUMSMITH+BROWN, PC - Orion Biotech Opportunities Corp.fs12021ex23-1_orionbiotech.htm
S-1 - REGISTRATION STATEMENT - Orion Biotech Opportunities Corp.fs12021_orionbiotech.htm
EX-99.1 - CONSENT OF DIRECTOR NOMINEE - SAMUEL BRODER - Orion Biotech Opportunities Corp.fs12021ex99-1_orionbiotech.htm

Exhibit 99.2

 

CONSENT OF JAMES COLLINS

 

Orion Biotech Opportunities Corp. (the “Company”) intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.

 

February 24, 2021

 

  By: /s/ James Collins
  Name: James Collins